Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adagio Medical Holdings (ADGM) Capital Expenditures (2023 - 2025)

Adagio Medical Holdings (ADGM) has disclosed Capital Expenditures for 3 consecutive years, with -$491000.0 as the latest value for Q4 2025.

  • Quarterly Capital Expenditures changed N/A to -$491000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $597000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $374000.0 for FY2025, N/A changed from the prior year.
  • Capital Expenditures for Q4 2025 was -$491000.0 at Adagio Medical Holdings, down from $335000.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $578000.0 in Q3 2024, with the low at -$491000.0 in Q4 2025.
  • Average Capital Expenditures over 3 years is $180833.3, with a median of $250500.0 recorded in 2023.
  • Peak annual rise in Capital Expenditures hit 106.79% in 2025, while the deepest fall reached 106.79% in 2025.
  • Over 3 years, Capital Expenditures stood at $326000.0 in 2023, then surged by 77.3% to $578000.0 in 2024, then plummeted by 184.95% to -$491000.0 in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at -$491000.0, $335000.0, and $578000.0 for Q4 2025, Q1 2025, and Q3 2024 respectively.